drug · gene
aglatimagene besadenovec
Phase 3updated 3mo agoby $CADL Candel Therapeutics, Inc.🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Phase 3 (across all indications), with 8 investigational indications.
indications
indications
NSCLCProstate Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying aglatimagene besadenovec
- phase2A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- phase2CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
- phase3Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
- phase2Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
- phase2Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
News(1)
- Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate CancerMark Garzotto, MD, discusses efficacy data with aglatimagene besadenovec plus valacyclovir and EBRT in localized prostate cancer.onclive · 3mo ago
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that